1. Home
  2. CDZI vs NNNN Comparison

CDZI vs NNNN Comparison

Compare CDZI & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDZI
  • NNNN
  • Stock Information
  • Founded
  • CDZI 1983
  • NNNN 2021
  • Country
  • CDZI United States
  • NNNN Germany
  • Employees
  • CDZI N/A
  • NNNN N/A
  • Industry
  • CDZI Water Supply
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • CDZI Utilities
  • NNNN Health Care
  • Exchange
  • CDZI Nasdaq
  • NNNN Nasdaq
  • Market Cap
  • CDZI 238.2M
  • NNNN 267.7M
  • IPO Year
  • CDZI N/A
  • NNNN 2025
  • Fundamental
  • Price
  • CDZI $2.95
  • NNNN $7.87
  • Analyst Decision
  • CDZI
  • NNNN
  • Analyst Count
  • CDZI 0
  • NNNN 0
  • Target Price
  • CDZI N/A
  • NNNN N/A
  • AVG Volume (30 Days)
  • CDZI 412.0K
  • NNNN 44.5K
  • Earning Date
  • CDZI 05-14-2025
  • NNNN 01-01-0001
  • Dividend Yield
  • CDZI N/A
  • NNNN N/A
  • EPS Growth
  • CDZI N/A
  • NNNN N/A
  • EPS
  • CDZI N/A
  • NNNN 0.06
  • Revenue
  • CDZI $11,441,000.00
  • NNNN $8,185,146.00
  • Revenue This Year
  • CDZI $75.05
  • NNNN N/A
  • Revenue Next Year
  • CDZI $12.18
  • NNNN N/A
  • P/E Ratio
  • CDZI N/A
  • NNNN $140.27
  • Revenue Growth
  • CDZI 283.67
  • NNNN 21.95
  • 52 Week Low
  • CDZI $2.13
  • NNNN $5.18
  • 52 Week High
  • CDZI $5.68
  • NNNN $8.22
  • Technical
  • Relative Strength Index (RSI)
  • CDZI 52.32
  • NNNN N/A
  • Support Level
  • CDZI $2.76
  • NNNN N/A
  • Resistance Level
  • CDZI $3.06
  • NNNN N/A
  • Average True Range (ATR)
  • CDZI 0.17
  • NNNN 0.00
  • MACD
  • CDZI 0.01
  • NNNN 0.00
  • Stochastic Oscillator
  • CDZI 45.62
  • NNNN 0.00

About CDZI CADIZ Inc.

Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, which derives key revenue, and comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, which provides water filtration solutions for impaired or contaminated groundwater sources.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: